You are viewing archived information about TCT 2009 which was held September 21-25.
‹‹ Back to TCT 2010
TCT 2009 Program Search
| Featured Clinical Trials: First Report Investigations | | |  My Calendar |
|
| | Thursday, September 24, 2009
Room: 131
2:00 pm-5:45 pm |
| | |
| Session I. Drug-Eluting Stents |
|
| | 2:00 pm | ZEST: Final Angiographic and IVUS Results From a Large-Scale Randomized Trial of Zotarolimus-Eluting, Sirolimus-Eluting and Paclitaxel-Eluting Stents
Lecturer: Cheol Whan Lee |
|
| | 2:10 pm | Roundtable Discussion With Audience Q&A |
|
| | 2:15 pm | CEREA-DES: A Prospective Randomized Trial of Corticosteroids in Patients Undergoing Stent Implantation
Lecturer: Flavio L. Ribichini |
|
| | 2:25 pm | Discussion with Audience Q&A |
|
| | 2:30 pm | STATINS PRE-PCI: A Prospective Randomized Trial of Statins Prior to Stent Implantation in Patients with Stable Angina
Lecturer: Josef Veselka |
|
| | 2:40 pm | Discussion with Audience Q&A |
|
| | 2:45 pm | NEVO RES-ELUTION I QOL: Formal Quality-of-Life Assessment from a Prospective Randomized Trial of a Novel Sirolimus-Eluting Stent and a Paclitaxel-Eluting Stent
Lecturer: John A. Spertus |
|
| | 2:55 pm | Discussion with Audience Q&A |
|
| | 3:00 pm | CILOTAX: A Prospective, Randomized, Controlled Trial of a Stent Eluting Cilostazol and Paclitaxel
Lecturer: Cheol Whan Lee |
|
| | 3:10 pm | Discussion with Audience Q&A |
|
| | 3:15 pm | BIOFREEDOM: A Prospective Randomized Trial of a Polymer-Free Biolimus A9-Eluting Stent
Lecturer: Eberhard Grube |
|
| | 3:25 pm | Discussion with Audience Q&A |
|
| | 3:30 pm | Moderators' Summary of This Session |
| Session II. ACS Therapies and Novel Imaging Approaches |
|
| | 3:35 pm | MISTRAL: A Prospective Randomized Trial of Ambulance-Initiated vs. Cath Lab-Initiated Intravenous Abciximab in Patients with STEMI
Lecturer: Patrick Ohlmann |
|
| | 3:45 pm | Discussion with Audience Q&A |
|
| | 3:50 pm | COCKTAIL: A Prospective Randomized Trial of Intracoronary Abciximab Infusion in Patients with Thrombotic Lesions Assessed by OCT
Lecturer: Francesco Prati |
|
| | 4:00 pm | Discussion with Audience Q&A |
|
| | 4:05 pm | NO REFLOW: A Prospective Randomized Trial of Intracoronary vs. Guide Catheter Infusion of Nitrates vs. Calcium Channel Blockers in Patients with No Reflow After Primary PCI in STEMI
Lecturer: Junbo Ge |
|
| | 4:15 pm | Discussion with Audience Q&A |
|
| | 4:20 pm | OCTAMI: A Prospective Randomized Trial of Zotarolimus-Eluting and Bare-Metal Stents in STEMI Assessed by OCT
Lecturer: Giulio Guagliumi |
|
| | 4:30 pm | Discussion with Audience Q&A |
|
| | 4:35 pm | Moderators' Summary of This Session |
| Session III. End-Stage, Structural Heart and Endovascular Intervention |
|
| | 4:40 pm | The Canadian Transcatheter Aortic Valve Implantation Program: Acute and Late Follow-up from a Multicenter Consecutive Series of Patients with Inoperable or High-Surgical Risk Aortic Stenosis
Lecturer: Josep Rodes-Cabau |
|
| | 4:50 pm | Discussion with Audience Q&A |
|
| | 4:55 pm | CROSS-CLI: A Prospective Multicenter Registry of Ultrasound-Facilitated Recanalization of Peripheral Chronic Total Occlusions
Lecturer: Raghotham R. Patlola |
|
| | 5:05 pm | Discussion with Audience Q&A |
|
| | 5:10 pm | PROVASA: A Prospective, Randomized, Placebo-Controlled Trial of Intra-Arterial Progenitor Cell Transplantation of Bone Marrow Mononuclear Cells in Patients with Peripheral Arterial Occlusive Disease
Lecturer: Dirk H. Walter |
|
| | 5:20 pm | Discussion with Audience Q&A |
|
| | 5:25 pm | ACT34-CMI: One-Year Results from a Prospective, Randomized, Placebo-Controlled Phase II Trial of CD34+ Cells in Patients with Refractory Angina
Lecturer: Douglas W. Losordo |
|
| | 5:35 pm | Discussion with Audience Q&A |
|
| | 5:40 pm | Moderators' Summary of This Session |
View the Japanese version of this website.
